To include your compound in the COVID-19 Resource Center, submit it here.

Synthetic lethality company Ideaya raises $94M

Ideaya Biosciences Inc. (South San Francisco, Calif.) raised $94 million in a series B round led by Nextech

Read the full 180 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE